Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
50 studies found for:    Open Studies | "Gastrointestinal Stromal Tumors"
Show Display Options
Rank Status Study
21 Recruiting Prospective Cohort Study of the Clinical Applications for the Pathologic Type, Staging, and Grading of GIST
Condition: Gastrointestinal Stromal Tumor
Intervention: Other: follow up
22 Not yet recruiting The Stop-GIST Trial: Discontinuation of Imatinib in Patients With Oligo-metastatic GIST
Condition: Gastrointestinal Stromal Tumor
Intervention: Other: Discontinuation of imatinib
23 Recruiting A Clinical Trial Evaluating the Efficacy and Safety of Dasatinib in Refractory Metastatic GIST
Condition: Gastrointestinal Stromal Tumor
Intervention: Drug: dasatinib
24 Recruiting Phase 1 Study of BLU-285 in Patients With Gastrointestinal Stromal Tumors (GIST) and Other Relapsed and Refractory Solid Tumors
Conditions: Gastrointestinal Stromal Tumors (GIST);   Other Relapsed or Refractory Solid Tumors
Intervention: Drug: BLU-285
25 Not yet recruiting Phase II Study of Continuous Dosing of Regorafenib in Patients With Gastrointestinal Stromal Tumors (GISTs) After Failure of Imatinib and Sunitinib
Condition: Gastrointestinal Stromal Tumors (GISTs)
Intervention: Drug: Regorafenib
26 Not yet recruiting Ph II CABOGIST in GIST
Condition: Metastatic Gastrointestinal Stromal Tumor
Intervention: Drug: cabozantinib
27 Recruiting Regorafenib in GIST With Secondary C-KIT Exon 17 Mutation
Condition: Gastrointestinal Stromal Tumour (GIST)
Intervention: Drug: regorafenib
28 Recruiting A Study of Intermittent Dosing Schedule of Imatinib in Patients With Tyrosine Kinase Inhibitor Refractory GISTs
Condition: Gastrointestinal Stromal Tumors (GISTs)
Intervention: Drug: Imatinib Mesylate
29 Not yet recruiting Efficacy of Ferric Carboxymaltose in Patients With Gastrointestinal Stromal Tumor (GIST) Receiving Systemic Therapy
Conditions: Malignant Neoplasms of Mesothelial and Soft Tissue;   Gastrointestinal Stromal Tumor With Neurogenic Differentiation
Interventions: Drug: Ferric Carboxymaltose;   Dietary Supplement: Iron Supplements;   Behavioral: Questionnaire
30 Recruiting Influence of an Acidic Beverage on the Imatinib Exposure After Major Gastrectomy
Conditions: Gastrointestinal Stromal Tumor;   Major Gastrectomy
Intervention: Dietary Supplement: cola
31 Recruiting Surgery for Locally Unresectable Advanced GISTs Without Metastasis After Imatinib Therapy
Condition: Gastrointestinal Stromal Tumor
Intervention:
32 Not yet recruiting MITIGATE-NeoBOM: A Study to Evaluate 68Ga- NeoBOMB1 in Patients With Advanced TKI-treated GIST Using PET/CT
Condition: Gastrointestinal Stromal Tumors
Intervention: Drug: 68Ga-NeoBOMB1, 2-vial kit
33 Recruiting Single Agent Regorafenib in First-line for Metastatic/Unresectable KIT/PDGFR Wild Type GIST
Condition: Gastrointestinal Stromal Tumors
Intervention: Drug: regorafenib
34 Recruiting Imatinib Dose Escalation to 800 mg/Day in Korean Patients With Metastatic or Unresectable GIST Harboring KIT Exon 9 Mutation
Condition: Gastrointestinal Stromal Tumors
Intervention: Drug: imatinib
35 Recruiting The Effects of the Proton Pump Inhibitor Esomeprazole on the Bioavailability of Regorafenib
Conditions: Colorectal Neoplasms;   Gastrointestinal Stromal Tumors
Interventions: Drug: Esomeprazole 40mg concomitantly;   Drug: Esomeprazole 40mg before;   Drug: Regorafenib 160mg or 120mg
36 Recruiting Efficiency of Imatinib Treatment Maintenance or Interruption After 3 Years of Adjuvant Treatment in Patients With Gastrointestinal Stromal Tumours (GIST)
Conditions: Gastrointestinal Stromal Tumors;   Resected Gastrointestinal Stromal Tumors;   Non-metastatic;   High Risk of Recurrence;   KIT Gene Mutation
Intervention: Drug: Imatinib maintenance
37 Recruiting Treatment Response Evaluation in Gastrointestinal Stromal Tumor (GIST) Patients
Conditions: Soft Tissue Neoplasms;   Gastrointestinal Tract
Intervention:
38 Recruiting Long Term Effects of Tyrosine Kinase Inhibitor Therapy on Ovarian Reserve and Fertility in Patients With Chronic Myeloid Leukemia or Gastrointestinal Stromal Tumor
Conditions: Chronic Myelogenous Leukemia, BCR-ABL1 Positive;   Gastrointestinal Stromal Tumor;   Premenopausal
Interventions: Other: Cytology Specimen Collection Procedure;   Other: Laboratory Biomarker Analysis;   Other: Questionnaire Administration;   Procedure: Ultrasonography
39 Recruiting Endoscopic Full Thickness Resection of Gastric Subepithelial Tumors (FROST)
Conditions: Gastric Neoplasms;   Gastrointestinal Stromal Tumors
Intervention: Device: GERDX(TM)
40 Recruiting Registry For Temsirolimus, Sunitinib, And Axitinib Treated Patients With Metastatic Renal Cell Carcinoma (mRCC), Mantle Cell Lymphoma (MCL), And Gastro-Intestinal Stroma Tumor (GIST) [STAR-TOR]
Conditions: Carcinoma, Renal Cell, Advanced;   Lymphoma, Mantle-Cell;   Gastrointestinal Stroma Tumors
Interventions: Drug: Temsirolimus;   Drug: Sunitinib;   Drug: Axitinib

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-50) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.